采用不同临床评分系统评估某医院狼疮激素用量的合理性分析

目的  采用系统性红斑狼疮疾病活动指数2000（systemic lupus erythematosus disease activity index 2000，SLEDAI-2000）、英国狼疮评估组指数2004（revised british Isles lupus assessment group index 2004，BILAG-2004）、系统性红斑狼疮活动性测定（systemic lupus activity measure-revised，SLAM-R）三种评分系统评估糖皮质激素（glucocorticoid，GC）在系统性红斑狼疮治疗中的规范化用量。 方法  收集51例初诊的系统性红斑狼疮病人的临床资料，分别应用SLEDAI-2000、BILAG-2004、SLAM-R三种评分系统判断狼疮的活动度。进行三种评分和泼尼松用量（或转换后等同的泼尼松用量）的相关性分析。 结果  三种评分系统均与泼尼松的累计剂量和每日剂量成正相关，其中BILAG-2004评分与泼尼松用量的相关性最好（r=0.827，P<0.001），SLAM-R评分与泼尼松用量的相关系数最低（r=0.512，P<0.001），SLEDAI-2000评分与泼尼松用量相关系数（r=0.584，P<0.001）。泼尼松的不同用法与不同的器官/系统受累有关。 结论  三种评分系统均可为临床上泼尼松用量的选择提供参考，但BILAG-2004评估系统更全面可靠。

Rationality evaluation of predisone dosage in the treatement of SLE with different clinical scoring systems

  Objective  To evaluate the rationality of predisone dosage in the treatement of SLE with different clinical scoring systems.  Methods  The clinical data of 51 newly diagnosed patients with systemic lupus erythematosus(SLE) were collected, and disease activity was assessed by SLEDAI- 2000, BILAG- 2004 and SLAM-R scoring systems. The correlations between SLEDAI- 2000, BILAG- 2004, SLAM-R scores and prednisone dosage were analyzed.  Results  BILAG-2004 score showed the best correlation with the dosage of prednision (r=0.827, P<0.001).SLAM score showed the worst correlation with the dosage of prednision (r=0.512, P<0.001). Different treatment choice was associated with different organ/system involvement.  Conclusions  BILAG- 2004, SLEDAI- 2000 and SLAM-R scoring systems all can be used as references for the prednisone dosage slection.It is suggested that the BILAG- 2004 scoring system is more reliable and comprehensive in clinical practice.